Uranus Chemicals Co., LTD.

TPEX:7742 Stock Report

Market Cap: NT$2.7b

Uranus Chemicals Balance Sheet Health

Financial Health criteria checks 4/6

Uranus Chemicals has a total shareholder equity of NT$1.7B and total debt of NT$447.3M, which brings its debt-to-equity ratio to 26.8%. Its total assets and total liabilities are NT$2.7B and NT$1.0B respectively. Uranus Chemicals's EBIT is NT$105.3M making its interest coverage ratio 101.4. It has cash and short-term investments of NT$331.4M.

Key information

26.8%

Debt to equity ratio

NT$447.31m

Debt

Interest coverage ratio101.4x
CashNT$331.44m
EquityNT$1.67b
Total liabilitiesNT$1.03b
Total assetsNT$2.69b

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: 7742's short term assets (NT$966.6M) exceed its short term liabilities (NT$694.0M).

Long Term Liabilities: 7742's short term assets (NT$966.6M) exceed its long term liabilities (NT$331.6M).


Debt to Equity History and Analysis

Debt Level: 7742's net debt to equity ratio (6.9%) is considered satisfactory.

Reducing Debt: Insufficient data to determine if 7742's debt to equity ratio has reduced over the past 5 years.

Debt Coverage: 7742's operating cash flow is negative, therefore debt is not well covered.

Interest Coverage: 7742's interest payments on its debt are well covered by EBIT (101.4x coverage).


Balance Sheet


Discover healthy companies